pamidronate has been researched along with Paraganglioma, Gangliocytic in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Loh, K | 1 |
| Matthay, KK | 1 |
| Hoover, M | 1 |
| Bracho, FA | 1 |
| Cortez, AB | 1 |
| Conte, FA | 1 |
| Albanese, CT | 1 |
| Miller, TR | 1 |
| Price, DC | 1 |
| Flores, AJ | 1 |
| Kaviani, A | 1 |
| Shoback, D | 1 |
1 other study available for pamidronate and Paraganglioma, Gangliocytic
| Article | Year |
|---|---|
Hypercalcemia in malignant paraganglioma due to parathyroid hormone-related protein.
Topics: Adolescent; Diphosphonates; Humans; Hypercalcemia; Male; Pamidronate; Paraganglioma; Parathyroid Hor | 1998 |